Literature DB >> 21976754

Actinobaculum bacteremia: a report of 12 cases.

Eric Gomez1, Daniel R Gustafson, Jon E Rosenblatt, Robin Patel.   

Abstract

Actinobaculum species are anaerobic Gram-positive rods that have previously been associated with urinary tract infection (UTI) in the elderly. We report 12 patients with Actinobaculum bacteremia. Only 40% of blood cultures were clinically considered significant by the treating physicians, but most patients were treated for UTI, suggesting a possible urinary source of bacteremia. Clinicians should be aware of the pathogenic potential of Actinobaculum spp.

Entities:  

Mesh：

Year:  2011        PMID： 21976754      PMCID： PMC3232933          DOI： 10.1128/JCM.00798-11

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  15 in total

1.  Characterization of some Actinomyces-like isolates from human clinical specimens: reclassification of Actinomyces suis (Soltys and Spratling) as Actinobaculum suis comb. nov. and description of Actinobaculum schaalii sp. nov.

Authors:  P A Lawson; E Falsen; E Akervall; P Vandamme; M D Collins
Journal:  Int J Syst Bacteriol       Date:  1997-07

2.  Actinobaculum massiliae: a new cause of superficial skin infection.

Authors:  David J Waghorn
Journal:  J Infect       Date:  2004-04       Impact factor: 6.072

3.  [Actinobaculum schaali bacteremia in an aged male patient].

Authors:  C Martinaud; T Gaillard; J Maslin; P Rivière; R Fournier; F Trueba; P Brisou
Journal:  Med Mal Infect       Date:  2008-10-30       Impact factor: 2.152

4.  Ten cases of Actinobaculum schaalii infection: clinical relevance, bacterial identification, and antibiotic susceptibility.

Authors:  Mark Reinhard; Jørgen Prag; Michael Kemp; Keld Andresen; Belinda Klemmensen; Niels Højlyng; Susan Hildebrand Sørensen; Jens Jørgen Christensen
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

5.  Isolation of Eubacterium suis from sows with cystitis.

Authors:  R L Walker; N J MacLachlan
Journal:  J Am Vet Med Assoc       Date:  1989-10-15       Impact factor: 1.936

6.  "Actinobaculum massiliae," a new species causing chronic urinary tract infection.

Authors:  Gilbert Greub; Didier Raoult
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

7.  Isolation of Actinobaculum schaalii and Actinobaculum urinale from a patient with chronic renal failure.

Authors:  Faiz Fendukly; Björn Osterman
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

8.  Urosepsis with Actinobaculum schaalii and Aerococcus urinae.

Authors:  P D J Sturm; J Van Eijk; S Veltman; E Meuleman; T Schülin
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

9.  Actinobaculum schaalii: clinical observation of 20 cases.

Authors:  C Beguelin; D Genne; A Varca; M-L Tritten; H H Siegrist; K Jaton; R Lienhard
Journal:  Clin Microbiol Infect       Date:  2010-11-10       Impact factor: 8.067

Review 10.  Vertebral osteomyelitis caused by Actinobaculum schaalii: a difficult-to-diagnose and potentially invasive uropathogen.

Authors:  P Haller; T Bruderer; S Schaeren; G Laifer; R Frei; M Battegay; U Flückiger; S Bassetti
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-09       Impact factor: 3.267
View more
  16 in total

Review 1.  Actinomyces and related organisms in human infections.

Authors:  Eija Könönen; William G Wade
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

2.  High mortality associated with Catabacter hongkongensis bacteremia.

Authors:  Susanna K P Lau; Rachel Y Y Fan; Hoo-Wing Lo; Ricky H Y Ng; Samson S Y Wong; Iris W S Li; Alan K L Wu; Kenneth H L Ng; Steven Tseung; Rodney A Lee; Kitty S C Fung; Tak-Lun Que; Kwok-Yung Yuen; Patrick C Y Woo
Journal:  J Clin Microbiol       Date:  2012-04-18       Impact factor: 5.948

3.  Clinical Significance of Commensal Gram-Positive Rods Routinely Isolated from Patient Samples.

Authors:  Sixto M Leal; Melissa Jones; Peter H Gilligan
Journal:  J Clin Microbiol       Date:  2016-09-14       Impact factor: 5.948

Review 4.  Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract.

Authors:  Kimberly A Kline; Amanda L Lewis
Journal:  Microbiol Spectr       Date:  2016-04

Review 5.  Urinary Microbiome: Yin and Yang of the Urinary Tract.

Authors:  Virginia Perez-Carrasco; Ana Soriano-Lerma; Miguel Soriano; José Gutiérrez-Fernández; Jose A Garcia-Salcedo
Journal:  Front Cell Infect Microbiol       Date:  2021-05-18       Impact factor: 5.293

6.  Presumed Septic Shock Caused by Actinotignum schaalii Bacteremia.

Authors:  Takehiro Hashimoto; Masaru Ando; Kosaku Komiya; Yuko Usagawa; Mari Yamasue; Kenji Umeki; Shin-Ichi Nureki; Kazufumi Hiramatsu; Jun-Ichi Kadota
Journal:  Intern Med       Date:  2021-02-01       Impact factor: 1.271

7.  Actinobaculum schaalii: identification with MALDI-TOF.

Authors:  T Tuuminen; P Suomala; I Harju
Journal:  New Microbes New Infect       Date:  2014-02-05

8.  Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study.

Authors:  Antonin Bal; Karen Brengel-Pesce; Alexandre Gaymard; Grégory Quéromès; Nicolas Guibert; Emile Frobert; Maude Bouscambert; Mary-Anne Trabaud; Florence Allantaz-Frager; Guy Oriol; Valérie Cheynet; Constance d'Aubarede; Amélie Massardier-Pilonchery; Marlyse Buisson; Julien Lupo; Bruno Pozzetto; Pascal Poignard; Bruno Lina; Jean-Baptiste Fassier; Florence Morfin; Sophie Trouillet-Assant
Journal:  Sci Rep       Date:  2021-07-22       Impact factor: 4.379

9.  Actinobaculum schaalii an emerging pediatric pathogen?

Authors:  Petra Zimmermann; Livia Berlinger; Benjamin Liniger; Sebastian Grunt; Philipp Agyeman; Nicole Ritz
Journal:  BMC Infect Dis       Date:  2012-08-28       Impact factor: 3.090

10.  Single clinical isolates from acute uncomplicated urinary tract infections are representative of dominant in situ populations.

Authors:  Dana Willner; Serene Low; Jason A Steen; Narelle George; Graeme R Nimmo; Mark A Schembri; Philip Hugenholtz
Journal:  MBio       Date:  2014-02-25       Impact factor: 7.867
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.